Table 1

Demographic and clinical parameters

VariableTLE, n=74LTLE, n=43RTLE, n=31P
Age§34.5 (12)34.7 (SD 12)32.1 (SD 10)p=0.1*
Female gender, %55.844.067.0p=0.06‡
Age at first seizure§15.3 (10.7)15.4 (SD 10)13.8 (SD 9)p=0.3*
Weekly frequency of seizures¶1 (5–3)1 (0.75–5) (5.8)1 (0.5–2)p=0.1*
 Self-reported seizure predominance, N (%)
 No predominance56.758.154.8p=0.8‡
 Sleep predominance13.511.616.1
 Wakefulness predominance16.218.612.9
 Only during wakefulness13.511.616.1
Antiseizure drugs, N (%)
 One drug10.89.312.9p=0.4‡
 Two drugs45.941.951.6
 Three drugs32.439.522.6
 Four drugs10.89.312.9
 Benzodiazepines/fenobarbital use37.841.932.3p=0.4†
MRI findings (%)
 Normal MRI23.09.429.3p=0.1‡
 Mesial sclerosis36.537.717.1
 Cortical dysplasia10.85.712.2
 Low grade tumour13.515.14.9
 Chronic sequelae16.213.212.2
  • *Unpaired T test.

  • †Fisher test.

  • ‡χ2 test.

  • §Mean (standard deviation).

  • ¶Median (IQR).

  • LTLE, left temporal lobe epilepsy; RTLE, right temporal lobe epilepsy; TLE, temporal lobe epilepsy.